Stay updated on CTI-1601 vs Placebo in Friedreich's Ataxia Clinical Trial
Sign up to get notified when there's something new on the CTI-1601 vs Placebo in Friedreich's Ataxia Clinical Trial page.

Latest updates to the CTI-1601 vs Placebo in Friedreich's Ataxia Clinical Trial page
- Check2 days agoChange DetectedThe page shows a revision update from v3.4.0 to v3.4.1. This appears to be a minor version update that does not affect the study details or core functionality.SummaryDifference0.1%

- Check9 days agoChange DetectedAdded a 'Show glossary' feature and updated several labels, including capitalization changes to 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', plus the revision note to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe Revision label changes from v3.3.3 to v3.3.4, a minor metadata update with no impact on study information.SummaryDifference0.1%

- Check45 days agoChange DetectedDifference0.2%

- Check74 days agoChange DetectedFooter revision label updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check81 days agoChange DetectedRemoved the government funding operating status notice from the page; this does not impact the study information presented. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to CTI-1601 vs Placebo in Friedreich's Ataxia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CTI-1601 vs Placebo in Friedreich's Ataxia Clinical Trial page.